Overview
- CVS and Walgreens will start selling the abortion pill mifepristone in some US states, following a 2023 FDA decision.
- The move is hailed by President Biden as an important milestone for reproductive freedom amid ongoing political debates.
- The Supreme Court is set to hear a case on limiting access to mifepristone, with implications for the upcoming election.
- Medication abortion, which includes mifepristone, is the most common method of abortion in the US.
- Critics argue the FDA has abandoned its responsibility to protect life, while supporters highlight the safety and effectiveness of the drug.